awmsg logo


AWMSG medicines optimisation guidance documents undergo national consultation prior to endorsement and publication. The following documents are currently under consultation and the views of healthcare professionals, industry representatives and patients/patient groups are welcomed. Please complete the associated pro-forma and return to

Please note: Comments received during consultation are compiled in a report and considered by the development group. Each comment will be addressed and any changes to the document that are made as a result will be noted. The summary report including any comments submitted will be available upon request.

AWTTC reserves the right to summarise comments, where it is deemed appropriate, and to not publish comments if we consider their publication to be unlawful or otherwise inappropriate.

By submitting your comments, you are agreeing to them being used in line with the above.

To request a consultation comment summary, please contact: Please allow three weeks from the close of the consultation period for the summary to be available.

There are currently no consultations available; please check back again soon.